Evaluation of Mumps Antibodies after Measles-Mumps-Rubella (MMR) Vaccines
スポンサーリンク
概要
- 論文の詳細を見る
Mumpus antibody titers before and after administration of MMR trivalent combined vaccines from 3 different company were evaluated by mumps IgG Enzyme Linked Immunosorbent Assay (ELISA) and by neutralizing antibody test (NT). Seroconversion rates determined with the ELISA were around 90% in all 3 different vaccines. The seroconversion by NT test ranged from 63% to 77%. The mumps ELISA is more sensitive method of determination of antibodies against mumps virus than NT. Since ELISA is a much simpler and easier method of determining antibodies than NT, it will be a method of choice in many clinical laboratories.
- 東海大学の論文
著者
-
Kimura M
Department Of Physiology St. Marianna University School Of Medicine
-
KUNO-SAKAI Harumi
Department of Pediatrics, School of Medicine, Totaki University
-
KIMURA Mikio
Department of Pediatrics, School of Medicine, Totaki University
-
OZAKI Kazuyo
Department of Pediatrics, School of Medicine, Totaki University
-
Mikio Kimura
Department Of Pediatrics School Of Medicine Tokai University
-
Kimura Mikio
Department Of Infectious Diseases And Applied Immunology Institute Of Medical Science The University
-
Ozaki Kazuyo
Department Of Pediatrics School Of Medicine Tokai University
-
Kuno‐sakai H
Department Of Community Health School Of Medicine Tokai University
-
Kuno-sakai Harumi
Department Of Pediatrics Medicine School Of Medicine Tokai University
-
Kimura Mikio
Department Of Infectious Diseases & Applied Immunology Institute Of Medical Science University O
-
Kuno-Sakai Harumi
Department of Community Health, School of Medicine, Tokai University
-
Kimura Mikio
Department of Chemistry, Faculty of Science and Engineering, Saga University
関連論文
- Effects of Spaceflight on Enzyme Activities and Ultrastructure of Fast-Type Skeletal Muscles of Rats
- A-band Movement and Junctional Gap Dissociation during Caffeine-induced Contracture of Skeletal Muscle Fibers
- Identification of the four species of human malaria parasites by nested PCR that targets variant sequences in the small subunit rRNA gene
- Single Locus Analysis of Allelic Variation in the Plasmodium falciparum MSP1 Gene of Field Isolates(Abstracts from the Malaria Workshop)
- Japanese Clinical Trials with Takeda Acellular Pertussis Vaccine(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- A Trial of Alloreactive T-cell Depletion Using Biotinylated Galactose Oxidase for the Prevention of Acute Graft-versus-Host Diseases
- Trial of Isolation of a Virus from Sera of Patients with Kawasaki Disease
- Polyclonal Increases of Serum Immunoglobulins and Increase of Immunoglobulin-Bearing Peripheral Blood Lymphocytes in Children with Kawasaki Disease
- Bone Marrow Transplantation in Children
- Allogeneic Bone Marrow Transplantation in Children : Tokai Experience 1982 to 1984
- Usefulness of a New DNA Diagnostic Method for Malaria; Microtiter Plate-Hybridization(Abstracts from the Malaria Workshop)
- CASES OF OVALE MALARIA AND MALARIAE MALARIA SUCCESSFULLY TREATED WITH MEFLOQUINE
- Relative frequencies of polymorphisms of variation in Block 2 repeats and 5' recombinant types of Plasmodium falciparum msp 1 alleles
- A PCR Method for Molecular Epidemiology of Plasmodium falciparum Msp-1
- Adverse events associated with MMR vaccines in Japan
- Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin
- Aerosol Infection Test for Evaluation of Pertussis Vaccine(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Characterization and Clinical Study on the Acellular Pertussis Vaccine Produced by a Combination of Column Purified Pertussis Toxin and Filamentous Hemagglutinin(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis
- Pertussis Vaccine Acceptance Rates and Incidence of Pertussis in Forty Seven Districts (Prefectures) in Japan Since 1977(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Evaluation of Mumps Antibodies after Measles-Mumps-Rubella (MMR) Vaccines
- Removal of Digitalis from Human Plasma using Immunoadsorbents
- Correlation of the Modified Scratch Test with the Radioallergosorbent Test (RAST) in Atopic Children
- Effects and Side Effects of a New Trivalent Combined Measles-Mumps-Rubella (MMR) Vaccine
- A Rapid Solid Phase Radioimmunoassay of Virus Particles
- Clinical and Bacteriological Profiles of Patients with Typhoid Fever Treated during 1975-1998 in the Tokyo Metropolitan Komagome Hospital
- Simple Microassay of Urinary Protein using a Membrane Filter
- Dissociation of Digoxin-Antibody Complex after Addition of Dextran-Coated Charcoal in the Radioimmunoassay of Digoxin
- Enzyme Linked Immunosorbent Assay of Rubella Antibody
- Dynamics of Transplacental Transmission of Pertussis Antibodies in Premature and Full Term Infants
- Evaluation of polymerization-dependent changes in color and translucency of resin composites using two formulae
- A rapid, simple and sensitive flow cytometric system for detection of Plasmodium falciparum
- Reports on Cases of Neurological Illnesses Occurring after Administration of Acellular Pertussis Vaccines in Japan(B. Vaccine Schedules: Their Pelationship to Current Epidemiology)(II. The Eradication of Pertussis: Current Unsolved Epidemiologic, Clinical
- Experiences with Acellular Pertussis Vaccine in Japan and Epidemiology of Pertussis
- Epidemiology of Pertussis in Japan(I. Current Situation of Acellular Pertussis Vaccines)(Clinical Aspects of Acellular Pertussis Vaccines)
- Syntheses and properties of [1,1'-bis(.ALPHA.-aminoisobutyric acid)]gramicidin S and [1-.ALPHA.-aminoisobutyric acid]semigramicidin S.
- Field Trial with a Further Attenuated Live Measles Virus Vaccine
- Complement Requirement of the Neutralizing Antibody Appearing After Immunization with Smallpox Vaccine